Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Retatrutide for Sale > Retatrutide CAS:2381089-83-2High-purity obesity treatment for fat loss is in stock
Retatrutide CAS:2381089-83-2High-purity obesity treatment for fat loss is in stock buy - large image1
Retatrutide CAS:2381089-83-2High-purity obesity treatment for fat loss is in stock buy - image1
Retatrutide CAS:2381089-83-2High-purity obesity treatment for fat loss is in stock buy - image2
Retatrutide CAS:2381089-83-2High-purity obesity treatment for fat loss is in stock buy - image3
Retatrutide CAS:2381089-83-2High-purity obesity treatment for fat loss is in stock buy - image4
Retatrutide CAS:2381089-83-2High-purity obesity treatment for fat loss is in stock buy - image5
Retatrutide CAS:2381089-83-2High-purity obesity treatment for fat loss is in stock buy - image6

Retatrutide CAS:2381089-83-2High-purity obesity treatment for fat loss is in stock

TDS 6561 Inquiries

Unit Price:

$50-60/UNIT FOB

Get Latest Price
CAS No.:

2381089-83-2

Grade:

Pharmaceutical Grade

Content:

99%

Port:

shenzhen

Brand:

Topi

Packaging:

40mg/vial, 10vials/box

Price valid (until):

2027-07-31

Company Type:
Trader
Location:
China
Qualification:
Main Products:

peptides,Semagiutide,Retatrutide,GHK-CU,MOTS-c,Semax

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail 


    Sales: Sophia
    Mail: 16632958910@163.com   
    Whatsapp: +852 60438729

    we sale full list with peptide products , any other requirements just contact me !!!

    Items Specifications
    Product Name Retatrutide
    Molecular Formula C221H342N46O68
    CAS NO. 2381089-83-2
    Function Weight loss
    Appearance White Powder


      Product Detail  


    Retatrutide is a triple glucagon, GIP, and receptor agonist. Retatrutide showed glucose control and weight loss in patients with type 2 diabetes mellitus (T2DM).Retatrutide (LY3437943) is a triple agonist peptide of the glucagon receptor (GCGR), glucosedependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor .Retatrutide can be used for the research of obesity.Normally, this peptide will be delivered in lyophilized form and should be stored in a freezer at or below -20 °C.


    1.     1.Treatment of depression and anxiety disorders:  Retatrutide  has been shown to have antidepressant and anxiolytic effects in preclinical studies, suggesting that it could be a promising treatment option for individuals with these conditions.
    2.     2.Prevention of neurodegenerative diseases:  Retatrutide  has neuroprotective properties that may be useful in preventing or slowing the progression of neurodegenerative diseases such as Alzheimer's and Parkinson's.
    3.     3.Enhancement of cognitive function:  Retatrutide has been shown to improve learning and memory in animal studies, suggesting that it could have potential as a cognitive enhancer in humans.
    4.     4.Treatment of chronic pain: Retatrutide has been shown to have analgesic effects in preclinical studies, suggesting that it could be a useful treatment option for individuals with chronic pain conditions.
    5.     5.Promotion of wound healing:  Retatrutide has been shown to accelerate wound healing in animal studies, suggesting that it could have potential as a therapeutic agent for promoting wound healing in humans.

    NOTE: This product was prepared by chemical synthesis. Used only for research. Not for human use.

    Shop Retatrutide CAS:2381089-83-2High-purity obesity treatment for fat loss is in stock-Detailed Image 1


    Shop Retatrutide CAS:2381089-83-2High-purity obesity treatment for fat loss is in stock-Detailed Image 2 Shop Retatrutide CAS:2381089-83-2High-purity obesity treatment for fat loss is in stock-Detailed Image 3 Shop Retatrutide CAS:2381089-83-2High-purity obesity treatment for fat loss is in stock-Detailed Image 4


    Product effect



    Shop Retatrutide CAS:2381089-83-2High-purity obesity treatment for fat loss is in stock-Detailed Image 5 Shop Retatrutide CAS:2381089-83-2High-purity obesity treatment for fat loss is in stock-Detailed Image 6

    Shop Retatrutide CAS:2381089-83-2High-purity obesity treatment for fat loss is in stock-Detailed Image 7







    Peptide action



    • Helps slow food leaving your stomach
    • Helps prevent your liver from making too much sugar
    • Helps the pancreas produce more insul when your blood sugar levels are high
    • Can help control blood glucose
    • Can reduce hyperglycemia, especially after meals
    • Can reduce fasting insul and fasting glucose
    • Can reduce hemoglobin A1c
    • Can decrease appetite and caloric intake, while inhibiting weight gain
    • Has been shown to lower triglyceride levels and oxidative stress from high LDL
    • Has been shown to help induce weight loss in obese patients with higher dosing
    • Helps decrease leptin and increase leptin sensitivity
    • Can increase the conversion of white fat to brown fat

    • Shop Retatrutide CAS:2381089-83-2High-purity obesity treatment for fat loss is in stock-Detailed Image 8 Shop Retatrutide CAS:2381089-83-2High-purity obesity treatment for fat loss is in stock-Detailed Image 9

     


    Product packaging


    Shop Retatrutide CAS:2381089-83-2High-purity obesity treatment for fat loss is in stock-Detailed Image 10


    Product transportation


    Shop Retatrutide CAS:2381089-83-2High-purity obesity treatment for fat loss is in stock-Detailed Image 11


    Payment modes  


    Shop Retatrutide CAS:2381089-83-2High-purity obesity treatment for fat loss is in stock-Detailed Image 12


      Company Profile 


    Hainan Terte New Materials Co., Ltd. It is located in Hainan Province, China, with well-developed land transportation and convenient sea transportation. We focus on the sales and practical application of chemical raw material products. We adhere to the business philosophy of "be a good person first, then do good deeds", with the aim of putting customers first, ensuring stable and reliable quality, and promoting honest cooperation. We provide services to enterprises across the country with enthusiastic service and reasonable prices. Our company warmly welcomes domestic and foreign merchants and friends to visit and patronize us. We are willing to join hands with friends from all walks of life to create a brilliant future together.

    Shop Retatrutide CAS:2381089-83-2High-purity obesity treatment for fat loss is in stock-Detailed Image 13 Shop Retatrutide CAS:2381089-83-2High-purity obesity treatment for fat loss is in stock-Detailed Image 14 Shop Retatrutide CAS:2381089-83-2High-purity obesity treatment for fat loss is in stock-Detailed Image 15

    Shop Retatrutide CAS:2381089-83-2High-purity obesity treatment for fat loss is in stock-Detailed Image 16


     FAQ


    1.Can we get your free samples?

    Yes, can. Our free sample can be provided for customers test. But the freight for express is obuyer's account.

    2.Can we do printing or label on the bottles?

    Yes, can. We can offer various printing ways,such, screen printing, hot stamping, label printing.

    3.What is the normal lead time?

    For stock products, within 24-48 hours after we receive your payment. For smaller customize color bottles, we will ship out within 3-5 days.

    4.What is your shipping terms?

    Faster ways: FEDEX, DHL, UPS, TNT, etc by sea or by air economy

    5.What payment methods are there?
    There are Bank Transfer, PayPal, Tether USD(USDT) and Bitcoin(BTC); we can also accept payments in CNY, for example, through Alipay or WeChat.

    ECHEMI Editorial Reference
    Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide inhibits human GCGR, GIPR and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively and mouse GCGR, GIPR, and GLP-1R with EC50 values of 2.32, 0.191 and 0.794 nM, respectively. It is an important tool for obesity research.Retatrutide potently activates the GLP-1R signaling pathway to stimulate glucose-dependent insulin secretion through activity at the GIP receptor (GIPR) or the GLP-1R.Retatrutide is a synthetic peptide with glucose-lowering effects. It is an antidiabetic agent against type 2 diabetes (T2D), stimulating insulin and suppressing glucagon secretion in a glucose-dependent manner.Retatrutide was also shown to delay gastric emptying, lower fasting and postprandial glucose concentration, decrease food intake and reduce body weight in patients with type 2 diabetes.

    Certificates

    Basic Info
    Product Name:

    Retatrutide

    Other Name:

    Retatrutide;GIPR/GLP-1R;LY3437943Retatrutide;Retalutide;Retatrutide (sodium salt);Retatrutide RT5;retatrutide 5mg;Retatratide

    CAS No.:

    2381089-83-2

    Molecular Formula:

    C221H342N46O68

    Molecular Weight:

    4731.33

    EC Number:

    200-001-8

    Color/Form:

    White lyophilized

    Characteristics
    Water Solubility:

    Soluble in water (5mg/ml).

    Storage Conditions:

    -20°C

    Critical Temperature & Pressure:

    -20°C

    Research
    Class:

    Triple agonist — GCGR, GIPR, GLP-1R

    Status:

    Investigational (Phase 3)

    Mechanism:

    Simultaneously activates glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Engineered from the native GIP backbone with amino acid substitutions to confer GCGR and GLP-1R activity.

    EC50 (Human GCGR):

    5.79 nM

    EC50 (Mouse GIPR):

    0.191 nM

    EC50 (Mouse GLP1R):

    0.794 nM

    EC50 (Mouse GCGR):

    2.32 nM

    EC50 (Human GLP1R):

    0.775 nM

    EC50 (Human GIPR):

    0.0643 nM

    Source:

    Jastreboff AM, et al. N Engl J Med. 2023;389(6):514-526.DOI

    Clinical Development:

    NCT04881760; NCT05882045; NCT06354660

    References
    ChEMBL:

    CHEMBL5095485

    DrugBank:

    DB18993

    KEGG DRUG:

    D12430

    PubChem:

    PubChem

    Disclaimer:

    Retatrutide is an investigational compound not yet approved by FDA or EMA. This listing is for industrial and laboratory research use only. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    peptides,Semagiutide,Retatrutide,GHK-CU,MOTS-c,Semax

    Location:

    Units 1503-14, 15th Floor, New HNA Building, No. 7 Guoxing Avenue, Lantian Subdistrict, Meilan District, Haikou City, Hainan Province

    Payment Terms:

    TT against copy of documents,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    3

    Total Annual Revenue:

    $2.5 million-$5 million

    Total Employees:

    101-200

    Year of Establishment:

    2025

  • Inquiry History
    6561 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Retatrutide 2381089-83-2

    3 MT Mar 28, 2026
    United Kingdom

    Retatrutide - 2381089-83-2

    1 G Feb 10, 2026
    United States

    Retatrutide CAS 2381089-83-2 10mg vial

    20 MT Mar 7, 2026
    United States

    Factory Retatrutide API 99% Purity CAS 2381089-83-2

    5 KG Nov 10, 2025
    United Kingdom

    Peptide powder Retatrutide 99% pure for Body building cas 2381089-83-2 Weight Loss Peptide with COA

    1 MT Mar 22, 2026
    United States

    2381089-83-2

    100 G Jul 14, 2026
    United States

    2381089-83-2

    100 G Feb 24, 2026
    United States

    2381089-83-2

    100 MT Dec 9, 2023
    United States

    Retatrutide 2381089-83-2

    200 MG May 16, 2026
    United Kingdom

    2381089-83-2 retatrutide

    300 MG Feb 13, 2026
    United States

    Retatrutide 2381089-83-2 wholesale

    500 MT Nov 3, 2023
    Poland

    CAS 2381089-83-2 (Custom Peptide)

    40 MT Apr 10, 2026
    Austria

    Peptide Retatruide CAS 2381089-83-2

    100 MT Apr 4, 2026
    United States

    Retatrutide CAS 2381089-83-2 99%

    10 PCS Feb 21, 2026
    Austria

    Retatrutide CAS 2381089-83-2 10mg vial

    20 PCS Feb 10, 2026
    United States

    GLP-1 / GIP Retatrutide cas 2381089-83-2

    1 MT Oct 16, 2024
    United States

    Tirzepatide 99.9% Liquid 2381089-83-2 TeruiOP

    1 MT Sep 6, 2023
    United States

    Retatrutide/LY3437943/GIPR/GLP-1R 98% Powder 2381089-83-2 Senwayer

    1 G Sep 3, 2023
    United States

    Retatrutide 99% High Quality CAS 2381089-83-2

    1 G Jan 23, 2026
    United States

    Injection Peptide Tirzepatide/Retatrutide/ Semaglutide Peptides CAS 2381089-83-2

    10  Oct 21, 2023
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.